Interestingly, treatment with SGLT2 inhibitors was reported to be associated with a reduced Tp-e/QT ratio and QT corrected dispersion, suggestive of a relative decrease in the risk for ventricular arrhythmias [31]. Here, SLC5A2 is linked to Ventricular arrhythmia.